Experimental antibody 'cocktail' protects animals from three deadly Ebola viruses - Mapp Biopharmaceutical, Inc.

Mapp Biopharmaceutical

Press Inquiries

About Us
Product Development
News
- In the News
- Press Releases
Publications
Job Openings
Expanded Access Policy
Contact Us

antibody

Search for:

Archives

July 2024
May 2024
October 2022
January 2021
June 2019
January 2019
September 2018

Categories

Press Releases

Recent News

New human trials for novel antibody offer hope for immediate protection against deadly Nipah

Jul 3, 2024

New human trials for novel antibody offer hope for immediate protection against deadly Nipah 3 July 2024; OSLO; CALIFORNIA; Twenty-five years after the first human outbreak of Nipah virus, a novel Nipah monoclonal antibody—which could offer people at risk of...

BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease

May 15, 2024

BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease As a part of ongoing national preparedness efforts against filoviruses, BARDA continues to support Mapp’s monoclonal antibody therapeutic,...

Additional Information

New Clinical Study
FCOI Policy
Purchase Order Terms and Conditions
Know Your Rights: Workplace Discrimination is Illegal
Institutional Biosafety Committee (NIH)
Affirmative Action Policy Statement for Protected Veterans and Individuals with Disabilities

Jobs Opportunities

© 2017-2024 Mapp Biopharmaceutical. All Rights Reserved.